Abstract
Caspase-6 activation occurs early in Alzheimer disease and sometimes precedes the clinical manifestation of the disease in aged individuals. The active Caspase-6 is localized in neuritic plaques, in neuropil threads, and in neurofibrillary tangles containing neurons that are not morphologically apoptotic in nature. To investigate the potential consequences of the activation of Caspase-6 in neurons, we conducted a proteomics analysis of Caspase-6-mediated cleavage of human neuronal proteins. Proteins from the cytosolic and membrane subcellular compartments were treated with recombinant active Caspase-6 and compared with undigested proteins by two-dimensional gel electrophoresis. LC/MS/MS analyses of the proteins that were cleaved identified 24 different potential protein substrates. Of these, 40% were cytoskeleton or cytoskeleton-associated proteins. We focused on the cytoskeleton proteins because these are critical for neuronal structure and function. Caspase-6 cleavage of alpha-Tubulin, alpha-Actinin-4, Spinophilin, and Drebrin was confirmed. At least one Caspase-6 cleavage site was identified for Drebrin, Spinophilin, and alpha-Tubulin. A neoepitope antiserum to alpha-Tubulin cleaved by Caspase-6 immunostained neurons, neurofibrillary tangles, neuropil threads, and neuritic plaques in Alzheimer disease and co-localized with active Caspase-6. These results imply that the early and neuritic activation of Caspase-6 in Alzheimer disease could disrupt the cytoskeleton network of neurons, resulting in impaired neuronal structure and function in the absence of cell death. This study provides novel insights into the pathophysiology of Alzheimer disease.
Highlights
Caspase-6 activation occurs early in Alzheimer disease and sometimes precedes the clinical manifestation of the disease in aged individuals
In Alzheimer disease (AD) brains, Csp6 is strongly activated in neuropil threads, neuritic plaques, and neurofibrillary tangles in the absence of classical apoptotic features [3]
The absence of active Csp6 in the nuclei of neurons combined with its presence in neurofibrillary tangles, neuritic plaques, and neuropil threads suggests that Csp6 is involved in neurodegeneration in AD
Summary
An in-gel digest with trypsin, which cuts C-terminal to a Lys or Arg residue, was done on the proteins, and the resulting peptides were extracted using acidic and basic conditions. All of these above steps were performed robotically (ProGest digestion robot, Genomic Solutions, Ann Arbor, MI). Digestion of in Vitro Translated (IVT) or Purified Proteins with Caspases—Proteins were digested for 4 h at 37 °C in Stennicke’s buffer with RCsp Western Blot Analyses—The rabbit neoepitope antiserum against Csp3-cleaved -actin (Fractin) was kindly provided by Dr Greg Cole (Department of Medicine, University of California, Los Angeles, CA) [41]. Total no. of peptides includes additional peptides that did not reach an expectation score of Ͻ10Ϫ3
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.